MedTrace Logo

Investigation of the Use of a Probiotic Supplement in People With Long COVID

NCT05975034 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2023-08-03

No results posted yet for this study

Summary

This study is a double-blinded randomised trial to assess the efficacy of a probiotic supplement in alleviating symptoms in people with Long COVID.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

Probiotic taken daily for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo taken daily for 12 weeks.

Sponsors & Collaborators

  • Symprove UK

    collaborator UNKNOWN

  • Biomesight

    collaborator UNKNOWN

  • Sheffield Hallam University

    lead OTHER

Principal Investigators

  • Caroline Dalton, PhD · Sheffield Hallam University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-12
Primary Completion
2023-12-11
Completion
2023-12-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05975034 on ClinicalTrials.gov